Heart rhythm showdown: ablation may beat drugs for ventricular tachycardia
NCT ID NCT05524077
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests whether a procedure called catheter ablation works better than anti-arrhythmic drugs for people with structural heart disease who have had a dangerous fast heart rhythm (ventricular tachycardia). About 162 participants will be randomly assigned to either ablation or standard drug therapy. The goal is to see which approach better reduces repeat episodes, life-threatening storms of fast rhythms, and death over about 18 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
catheter ablation (a procedure using a thin tube to destroy heart tissue causing abnormal rhythms)
What this could lead to
If successful, this could show that catheter ablation is a better first-line treatment than drugs for controlling dangerous heart rhythms and reducing hospital visits.
What could go wrong
This is a mid-sized trial (162 people) and results may not apply to all heart disease types. Ablation is invasive and carries risks like bleeding or heart damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gold Coast University Hospital
Southport, Queensland, 4215, Australia
-
John Hunter Hospital
New Lambton Heights, New South Wales, 2305, Australia
-
Nepean Hospital
Kingswood, New South Wales, 2747, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Royal North Shore Hospital
Saint Leonards, New South Wales, 2065, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
-
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
The Prince Charles Hospital
Chermside, Queensland, 4032, Australia
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia